Cite this paper
nullYan, S. , Li, Z. and Wu, G. (2009) Fitting evolutionary process of matrix protein 2 family from influenza A virus using analytical solution of differential equation. Journal of Biomedical Science and Engineering
, 587-593. doi: 10.4236/jbise.2009.28085
 S. Yan and G. Wu. (2009) Describing evolution of hemagglutinins from influenza A viruses using a differential equation, Protein Pept. Lett., 16, 794–804.
G. Wu and S. Yan. (2002) Randomness in the primary structure of protein: Methods and implications, Mol. Biol. Today, 3, 55–69.
G. Wu and S. Yan. (2006) Mutation trend of hemagglutinin of influenza A virus: A review from computational mutation viewpoint, Acta Pharmacol. Sin., 27, 513–526.
G. Wu and S. Yan. (2006) Fate of influenza A virus proteins, Protein Pept. Lett., 13, 377–384.
G. Wu and S. Yan. (2008) Lecture notes on computational mutation, Nova Science Publishers, New York.
T. Betakova. (2007) M2 protein-a proton channel of influenza A virus, Curr. Pharm. Des., 13, 3231–3235.
L. H. Pinto and R. A. Lamb. (2007) Controlling influenza virus replication by inhibiting its proton channel, Mol. Biosyst., 3, 18–23
J. Beigel and M. Bray. (2008) Current and future antiviral therapy of severe seasonal and avian influenza, Antiviral Res., 78, 91–102.
E. De Clercq and J. Neyts. (2007) Avian influenza A (H5N1) infection: Targets and strategies for chemotherapeutic intervention, Trends Pharmacol. Sci., 28, 280–285.
F. Hayden. (2009) Developing new antiviral agents for influenza treatment: What does the future hold? Clin. Infect. Dis., 48, S3–S13.
M. Schotsaert, M. De Filette, W. Fiers and X. Saelens. (2009) Universal M2 ectodomain-based influenza A vaccines: Preclinical and clinical developments, Expert Rev. Vaccines, 8, 499–508.
Influenza virus resources, (2009)
SPSS Inc., (2002) SigmaPlot for Windows, Version 8.02.
G. Wu. (1996) Fit fluctuating blood drug concentration: A beginner’s first note, Pharmacol. Res., 33, 379–383.
K. Yamaoka, T. Nakagawa and T. Uno. (1978) Application of Akaike’s information criterion (AIC) in the eva- luation of linear pharmacoketic equations, J. Pharmacokinet. Biopharm., 6, 165–175.
G. Wu, P. Cossettini and M. Furlanut. (1996) Prediction of blood cyclosporine concentrations in haematological patients with multidrug resistance by one-, two- and three-compartment models using Bayesian and nonlinear least squares methods, Pharmacol. Res., 34, 47–57.
G. Wu and S. Yan. (2006) Timing of mutation in hemagglutinins from influenza A virus by means of amino-acid distribution rank and fast Fourier transform, Protein Pept. Lett., 13, 143–148.
G. Wu and S. Yan. (2005) Timing of mutation in hemagglutinins from influenza A virus by means of unpredictable portion of amino-acid pair and fast Fourier transform, Biochem. Biophys. Res. Commun., 333, 70–78.
G. Wu and S. Yan. (2005) Searching of main cause leading to severe influenza A virus mutations and consequently to influenza pandemics/epidemics, Am. J. Infect. Dis., 1, 116–123.
S. Yan and G. Wu. (2009) Prediction of mutation position, mutated amino acid and timing in hemagglutinins from North America H1 influenza A virus, J. Biomed. Sci. Eng, 2, 190–199.